SUMMARY In previous studies from our laboratory a positive correlation between elevated blood ketone levels and the survival time (ST) during hypoxia (4-5% oxygen) was observed in fasted and alloxan diabetic mice. To test the hypothesis that ketosis was somehow increasing the tolerance of mice to hypoxia, we induced ketosis by either oral (PO), intraperitoneaJ (IP), or intravenous (IV) 1,3-butanediol (BD). Blood betahydroxybutyrate increased from 033 ± 0.06 mM to 3.32 ± 0.08 mM for PO, 1.2 ± 0.2 mM for IV and 0.83 ± 0.15 mM for IP. BD was associated with an increase in ST to 458% (n = 19) when given PO, 217% (n = 12) by IP route, and 560% (n = 13) by the IV route. The effect of ambient temperature (T a ) on this phenomenon was evaluated at 12, 22, 32, and 34° C. At each T., IV BD at 1.4 mmole/mouse was associated with an increase in ST to 525,559,151, and 145% of control, respectively. The absolute ST of both control and treated mice was greater at T. of 12 and 22°C than at 32 and 34°C. Rectal temperature was continuously recorded and no differences were detected between control and treated groups just prior to hypoxia except for the group treated at T. of 12°C. Hypoxia, however, was associated with a decrease in body temperature in each group. It is concluded that the artificial induction of ketosis by BD is associated with an increase in ST of mice exposed to hypoxia.
BRAIN SUBSTRATE availability
1^1 and the use of anesthesia 6 
"
9 have been reported to modify survival time or brain damage in various animals exposed to brain hypoxia and ischemia. In a previous study from our laboratory, 1 a correlation was noted between in- creased blood ketone levels and hypoxic tolerance. In other studies, in which elevated blood ketones could be predicted, an increased tolerance to hypoxia or ischemia has been noted. 1 - 3 On the basis of this correlation, it was desirable to determine if an intentional elevation in blood ketone levels could produce an increased tolerance of the brain for hypoxia. A wide variety of procedures can elevate blood ketone levels (i.e., fasting, ketogenic diet, uncontrolled diabetes). For this study we have chosen the non-toxic 101 ' alcohol 1,3-butanediol (BD). BD is converted in the body to beta-hydroxybutyrate (BHB) by alcohol dehydrogenase and aldehyde dehydrogenase.
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aldehyde dehydrogenases have their greatest activity in the liver. 15 The indirect elevation of blood ketones by BD was chosen because the constant conversion of BD to BHB produced a relatively stable level of BHB in the blood. In a subsequent study, the somewhat more complex dynamics of BHB administration in combination with glucagon (G) are evaluated in terms of the direct ketogenic modulation of hypoxic tolerance.
In this study we tested the hypothesis that the administration of BD, which is coincident with the elevation of blood ketones, can induce an increased tolerance to hypoxia that cannot be explained by the hypothermic effects of the alcohol.
Materials and Methods
The animal model used has been previously described by Wilhjelm and Arnfred, 8 Steen and Michenfelder," and used by our laboratory.
1 Adult male Sprague-Dawley albino mice (HA-ICR) weighing between 20 and 40 g were pretreated and then subjected to hypoxia (4-5% oxygen). The pretreatments involved the induction of ketosis by BD administered by one of 3 routes: IV, IP or PO. Body temperature, ambient temperature, survival time, or blood BHB levels were determined.
Experimental Hypoxia. For each trial, 2 control and 3 experimental animals were used. Each mouse was placed in an airtight, 110 ml flow through chamber. Five chambers were mounted in parallel and continuously flushed with a gas mixture. The composition of the gas mixture was continuously monitored with an oxygen analyzer (Beckman OM-14). The ambient temperature was maintained at one of 4 temperatures (13, 22, 32, or 34°C). Hypoxia was induced by first flushing the system at 1.7 1/min with an 8% oxygen, balance nitrogen, gas mixture. After 20-25 sec the chamber oxygen was reduced to between 4 and 5% at a flow rate of 1.3 1/min. The average oxygen content during the hypoxic period was 4.74 ± 0.04% (n = 92). Survival time, as used in this study and previous studies, 1 refers to the time from the onset of hypoxia (4-5%) to the cessation of spontaneous ventilation. Seven animals were exposed to hypoxia and, at the moment spontaneous ventilation stopped, were taken out of their chambers and immediately subjected to thoracotomy. In all 7 animals tested, the heart was still beating at thoracotomy. Thus, the cessation of respiration is probably not related to heart death and, likewise, contains no direct evidence of the exact time of brain death. Nonetheless, the procedure represents a simple, reproducible model of global hypoxia.
Temperature Measurements. Deep body temperature (T b ) was measured in each animal by inserting a thermocouple approximately 2 cm into the mouse's rectum. The thermocouple wire (36 gauge copperconstantin) was encased in polyethylene tubing (PE 50) and secured by tape to the mouse's tail. Body temperature was recorded at about 30 sec intervals using a temperature recorder (Honeywell Electronik 112). Cooling curves ( fig. 1 ) were generated with Time (minutes) rewarmed dead mice to determine the rate of decline in T b from a nonmetabolizing body. Separate curves were plotted for each of the ambient temperatures (T a ). Selected carcasses were heated above T a and then allowed to cool under the same conditions as the hypoxia experiments. The cooling curve data was taken to bracket the range of T b observed for each T a . The individual curves were averaged by recording elapsed time and T b from an arbitrary "zero" time. In order to test if the T. effects were peculiar to BD treated mice, a separate series of mice were treated with diazepam (7.5 mg/kg IV) and subjected to hypoxia at either 22 or 33°C.
1,3-Butanediol Administration. Five control Studies
were required to determine the route and amount of BD needed to induce ketosis as well as the time course of the induced elevation of BHB. In the first study, acute toxicity was tested in 68 mice given 0.25 ml injections containing from 1.1 to 7.7 mmoles BD. All intravenous (IV) injections were given in the tail vein. These mice were maintained under normal housing conditions and those that were alive after 2 days were considered survivors. In the second group of 34 mice, the blood BHB levels were measured at 9 intervals from 5 to 70 min after 1.4 mmoles BD, IV, per mouse.
In the third study, 60 mice were given 0.25 ml IV injections containing from 0.50 to 1.75 mmoles BD. After a 30 min wait, this group was tested for hypoxic tolerance. In the fourth group of 12 mice, 1.4 mmoles BD was given IP and after 30 min hypoxic tolerance was tested. Blood BHB Analysis. Representative mice from each group were treated as described above. Blood samples were taken by decapitating the mice and collecting the draining blood. One group of samples was deproteinized and neutralized for subsequent study by enzymatic analysis (beta-hydroxybutyrate dehydrogenase method) 19 on a Farrand Ratio Fluorometer-2. A second group of samples was rapidly centrifuged for 3 min and the plasma analyzed for BHB by spectrophotometry (Gilford 3500 computer-directed analyzer.) These 2 procedures showed no significant differences when compared so the results of each assay were combined. Each of the values for blood BHB were obtained under normoxic conditions because we were unable to obtain blood samples during hypoxia or at the moment of "death."
Data Analysis. Statistical analysis was performed with the aid of Michigan Interactive Data Analysis System (MIDAS) on an Amdahl 470/v7 computer facility. Comparison of survival time for each experimental group with the control group was done with Student's Mest unless the experimental group had animals that lived past the end of the predefined end of the testing period. In this case, comparisons were done by nonparametric analysis using the Wilcoxon-Mann-Whitney (WMW) Rank Sum test. All groups, with the exception of those with survivors, are expressed as mean ± standard error of the mean (SEM); the sample size is designated (n).
Results
Butanediol Administration. The acute toxicity of BD occurs over a very narrow range increasing from zero to 100% mortality between 2.2 and 4.4 mmoles per mouse ( fig. 2) . At a dose of 1.4 mmoles per mouse no mortality is observed under normoxic conditions. After administration of 1.4 mmoles per mouse BD, the blood level of BHB increases rapidly from a control level (saline injected mice) of 0.33 ± 0.06 mM (n = 15) to 1.20 ± 0.25 mM (n = 7) at 30 min ( fig. 3) . The increase in blood BHB is statistically significant (p < 0.01 Student's Mest) from 5 to 70 min after injection. A statistically significant (p < 0.05 WMW Rank Sum test) increase in average hypoxic survival time was observed 30 min after 0.75, 1.1, 1.4 and 1.67 mmoles per mouse BD ( fig. 4) . At 1.1 mmoles, 2 of 11 mice survived over 900 sec of hypoxia. At a dose of 1.4 mmoles BD 3 of 13 mice survived over 900 sec of hypoxia. In this series of animals the hypoxic test was considered over at 900 sec (15 min). In figure 4, these 5 "survivors" were averaged in as if they had died at 900 sec. If they are excluded completely the average sur-*This diet contains 4% salt mixture (JSP XVII, 27% vitamin free casein, 20% 1,3-butanediol, 30% non-nutritive cellulose, 10% cottonseed oil, and a total vitamin supplement. vival time is 301.8 ± 50.3 for the group receiving 1.1 mmoles and 529.2 ± 66.9 for the group receiving 1.4 mmoles of BD. At the highest dose given (1.67 mmoles/mouse) survival time was still almost twice that observed in controls. The major protective effect seen at lower doses ( fig. 4) was no longer present, presumably due to combinations with some osmotic or CNS toxicity at this high dose. Figure 5 shows the statistically significant (p < 0.0001 WMW Rank Sum test) increase in hypoxic survival time associated with PO, IV, and IP administration of BD. Mice alive after 3600 sec of hypoxia were considered "survivors" and included in the averages as if they had died at 3600 sec. Two of 19 in the PO group, 1 of 13 in the IV group, and none of 12 in the IP group were "survivors." If these 3 survivors are excluded completely, the average hypoxic survival times are 597.4 and 605.1 sec, respectively for PO and IV groups, each of which is statistically different from control {p < 0.001 Student's /-test). The filled dot over the control group represents a single aberrant mouse that is excluded from the average control because it had a survival time more than 5 standard deviations from the mean. The blood level of BHB was 3.32 ± 0.80 mM (n = 4) in the PO Temperature Effects. A statistically significant increase in hypoxic survival time was observed at each of the T a tested ( fig. 6 ). At the 2 lower T. the survival time was 550% of control and at the 2 higher T a 150% of control. Both the control and experimental groups had lower survival times at the higher T a . When polynomial regression of the cooling curve data ( fig. 1 ) is plotted along with the time course of cooling during hypoxia, no apparent difference in the rate of temperature decrease was observed between control and treated animals ( fig. 7 ). In the table it can be seen that no difference was detected in either initial T b or body weight in any of the control or experimental groups. The T b at the onset of hypoxia was lower at a T B of 12°C only in the treated mice. When individual T b at the onset of hypoxia is plotted against the corresponding survival time, there appears to be a negative correlation (fig. 8) . However, when P0 IV polynomial regression was done at the first through sixth levels, no r * greater than 0.5 was obtained. Diazepam produced a statistically significant increase in hypoxic survival time from 121.5 ± 17.9 to 257.2 ± 40.7 sec at a T a of 22.5°C. At a T a of 33.4°C no difference was detected between control and treated animals ( fig. 9 ).
Discussion
In this study blood BHB was intentionally elevated by PO, IV and IP administration of BD. As in previous studies, 1 ketosis was associated with an increased tolerance to hypoxia. The exact mechanism of this protection from hypoxia is obscure, but certain features of the phenomenon are beginning to emerge. There is no simple relationship between hypoxic tolerance and blood BHB. In fasted and experimental diabetic mice, 1 as well as in those treated with BD, the level of BHB in the blood and the duration of survival is not linearly related. Among other things, differences in blood glucose levels between the ketotic groups may account for some of the nonlinearity. 1 The evaluation FIGURE 5 . 
IP
of T b and T a in this response indicates that temperature can modify the protective effect of the ketosis induced by BD (figs. 6 & 8) . Neither T b nor T a , however, can account totally for this protection.
The mechanism we propose, whereby ketosis increases the brain's tolerance to hypoxia, involves the preferential metabolism of ketones, rather than glucose, as an energy substrate, thus minimizing the deleterious accumulation of brain lactic acid during hypoxia. The first requirement for this mechanism to operate is that BHB be available to the brain. The direct measurement of blood BHB indicates that at least the blood contains the necessary increase in ketones. An alternate source of BHB would be the conversion of BD in the brain to BHB. This is possible both because BD is a permeable alcohol and because the brain contains the appropriate enzymes for conversion of BD to BHB. 16 ' 18 Elevated BHB has been shown to be a negative modifier of brain phosphofructokinase 10 thus establishing the necessary conditions for the preferential metabolism of ketones. This inhibition of glucose breakdown would also minimize the accumulation of lactic acid during hypoxia. Ketogenic diets have been reported to have an anticonvulsive effect. 21 The results of the current study cannot rule out the possibility that anticonvulsive properties of ketones may likewise be responsible for the increased tolerance to hypoxia. Diazepam is well known for its anticonvulsive properties."" The increased hypoxic tolerance seen with diazepam, in our study, was eliminated by the elevations of T a . Unfortunately, BHB levels were not measured in these animals. A similar elevation in T a reduced, but did not eliminate, the protective effect of BD.
Another possible mechanism of protection might be attributable to a general reduction in cerebral function. The mice fed BD seemed behaviorally normal and those injected either IV or IP seemed more tranquil but still possessed motor capability and pain responses. There is little doubt that an alcohol such as BD could alter cerebral metabolism and/or function. T a in °C The extent to which such an alteration contributes to the protective effect is currently obscure. It should be noted, however, that ketosis induced by fasting and experimental diabetes 1 is also associated with an increase in hypoxic survival time.
It is concluded that elevated blood BHB is in part correlated with the increased tolerance to hypoxia seen in fasted, diabetic and butanediol-treated mice.
Other apparently minor components of this response are the hypothermic effect and a possible anticonvulsive or metabolic effect. Perhaps some of the variability in the relationship between BHB levels and hypoxic survival time can be accounted for by differing blood levels of other substrates and metabolically active hormones. The interaction between BHB and glucagon is the subject of another study. THE TOLERANCE OF MICE to hypoxia has been used by several laboratories as a model of cerebral hypoxia and ischemia. 13 Increases in hypoxic tolerance have been observed in several studies 1 -*• 5 when the systemic metabolism produced elevated blood beta-hydroxybutyrate (BHB). In many of the conditions used in these studies elevated blood glucagon (G) would be anticipated. The aim of this study was to determine if direct administration of BHB alone or in combination with G could modify survival time of mice which had been exposed to hypoxia (4-5% oxygen).
Hypoxic Tolerance Enhanced

Materials and Methods
The animal model used has been previously described by Wilhjelm and Arnfred, 2 Steen and Michenfelder* and used by our laboratory. 1 Adult
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male Sprague-Dawley albino mice (HA-ICR) weighing between 20 and 40 g were pretreated and after 30 min subjected to hypoxia (4-5% O 2 ). The pretreatments involved IV or IP injections of BHB with or without IV G. Corresponding injections of saline were given to each group. Body temperature, ambient temperature, survival time, or blood BHB levels were determined.
Experimental Hypoxia
For each trial, 2 control and 3 experimental animals were tested simultaneously. Each mouse was placed in an airtight, 110 ml flow-through chamber. Five chambers were mounted in parallel and continuously flushed with a gas mixture. The composition of the gas mixture flushing the chambers was continuously monitored with an oxygen analyzer (Beckman OM-14). The ambient temperature was maintained at 22°C. Hypoxia was induced by first flushing the system at 1.7 1/min with an 8% oxygen, balance nitrogen gas mixture. After 20-25 sec the chamber oxygen was reduced to between 4 and 5%, at a flow rate of 1.3 1/min. The exact level of oxygen in the chambers was recorded for each trial. The survival
